We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFA
276
DELISTED
Informatica
INFA
| $10.1M | 0.07% |
617,879
-55,937
| -8% | -$1M |
|
|
NXGN
277
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $10M | 0.07% |
532,784
-39,377
| -7% | -$759K |
|
278
Constellation Energy
CEG
$92B
| $9.94M | 0.07% |
+115,305
| New | +$10.4M |
|
|
TWOU
279
DELISTED
2U Inc
TWOU
| $9.94M | 0.07% |
52,827
-819
| -2% | -$162K |
|
280
Agilysys
AGYS
$3.18B
| $9.9M | 0.07% |
125,115
+14,637
| +13% | +$933K |
|
281
Gulfport Energy Corp
GPOR
$2.81B
| $9.9M | 0.07% |
134,411
-30,473
| -18% | -$2.52M |
|
|
ITOS
282
DELISTED
iTeos Therapeutics
ITOS
| $9.83M | 0.07% |
503,530
+37,205
| +8% | +$727K |
|
283
BridgeBio Pharma
BBIO
$16.6B
| $9.78M | 0.07% |
1,283,990
+83,912
| +7% | +$803K |
|
284
Cal-Maine
CALM
$4.44B
| $9.75M | 0.07% |
+179,102
| New | +$10.4M |
|
|
GMS
285
DELISTED
GMS Inc
GMS
| $9.66M | 0.07% |
194,020
-104,122
| -35% | -$4.99M |
|
286
NVR
NVR
$17.3B
| $9.52M | 0.06% |
2,063
-269
| -12% | -$1.18M |
|
287
Enova International
ENVA
$6.22B
| $9.47M | 0.06% |
246,703
-2,252
| -0.9% | -$82.2K |
|
288
MP Materials
MP
$7.02B
| $9.43M | 0.06% |
388,266
+305,465
| +369% | +$9.26M |
|
289
StoneX
SNEX
$8.73B
| $9.33M | 0.06% |
495,447
-29,519
| -6% | -$546K |
|
290
Eagle Materials
EXP
$6.57B
| $9.2M | 0.06% |
69,272
+31,814
| +85% | +$4.02M |
|
291
Northern Trust
NTRS
$22.1B
| $9.19M | 0.06% |
103,907
+28,547
| +38% | +$2.5M |
|
292
Columbia Sportswear
COLM
$3.21B
| $9.13M | 0.06% |
104,300
-110
| -0.1% | -$8.85K |
|
|
SGEN
293
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.12M | 0.06% |
70,972
-2,703
| -4% | -$349K |
|
|
MRC
294
DELISTED
MRC Global
MRC
| $9.11M | 0.06% |
786,606
+4,725
| +0.6% | +$49.8K |
|
|
WRK
295
DELISTED
WestRock Company
WRK
| $9.11M | 0.06% |
259,026
+9,421
| +4% | +$328K |
|
|
RDFN
296
DELISTED
Redfin
RDFN
| $9.07M | 0.06% |
+2,140,297
| New | +$10.1M |
|
|
NVRO
297
DELISTED
NEVRO CORP.
NVRO
| $9.05M | 0.06% |
228,540
+134,957
| +144% | +$5.61M |
|
298
DaVita
DVA
$15.5B
| $8.95M | 0.06% |
+119,862
| New | +$9.31M |
|
299
Apple Hospitality REIT
APLE
$3.97B
| $8.92M | 0.06% |
565,194
-28,621
| -5% | -$462K |
|
300
TripAdvisor
TRIP
$1.7B
| $8.91M | 0.06% |
495,471
-51,747
| -9% | -$1.08M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.